|
Announcing the Fall 2023 DC CFAR Pilot Awardees:
Dr. Randi Williams (Georgetown), Dr. Bethel Woldu (Georgetown),
and Dr. Ellen Yeung (GW)
| |
From left to right: Dr. Randi Williams, Dr. Bethel Woldu, and Dr. Ellen Yeung | |
Please join us in congratulating DC CFAR Investigators Dr. Randi Williams, Assistant Professor at Georgetown University, Dr. Bethel Woldu, Assistant Professor at Georgetown University, and Dr. Ellen Yeung, Assistant Professor at George Washington University who are the recipients of DC CFAR Pilot Awards for the Fall 2023 cycle.
The goal of the Traditional Pilot Awards program is to provide pilot research funds to early stage and new HIV/AIDS investigators to collect preliminary data that will enable them to then compete successfully for NIH funding in HIV/AIDS as principal investigators. During this cycle of the program, the DC Cohort provided a co-sponsorship opportunity to investigators by supplementing additional funds to awards. Dr. Williams' and Dr. Yeung's projects will work in collaboration with this large multi-center cohort of people with HIV who are receiving care at 14 clinics in DC.
Dr. Williams' project is entitled "Optimizing lung cancer control strategies for people with HIV” and will investigate lung cancer control strategies to inform new screening criteria for this population. Dr. Woldu's project is entitled, "Myocardial dysfunction on cardiac MRI and echocardiography in PLWH and correlates with serological biomarkers” and will investigate cardiac dysfunction in people with HIV using cardiac ultrasounds and MRI scans. Dr. Yeung's project is entitled, "The Multimorbidity of Alcohol Misuse, Chronic Pain, and Cognitive Impairment among People with HIV Aged 50 and Older” and will study the clinical impact and prevalence of these multimorbidities.
To read full descriptions of their awards, and to view past recipients of the Traditional Pilot Awards Program, please visit the DC CFAR website here.
| |
DC CFAR Women & HIV Scientific Interest Group (SIG) Meeting – Wed, Feb 21, from 4:00-5:00 PM EST | |
Please join the DC CFAR's Women and HIV SIG for its first meeting of the new year on Wednesday, February 21, from 4:00-5:00 PM ET. The Women and HIV SIG aims to create a platform to raise the visibility of girls and women, promote collaborations, and disseminate research focused on HIV and women.
At this kick-off meeting, the SIG leaders, Dr. Rachel Scott, Dr. Mimi Ghosh, Ms. J'Mia Edwards, and Ms. Tranessa Hanson, will plan to review the goals and proposed activities of the SIG. The group would then like to hear from participants about their topics of interest and areas of need in developing collaborations.
If you are interested in joining this meeting and receiving emails about the SIG, please contact Vivian Kirkham at vkirkham@gwu.edu.
| |
DC CFAR Implementation Science and Community Partnership Seminar Series: IS Study Design, Thu Feb 22, from 5:30-7:00 PM EST (HYBRID) | |
Please join us for our upcoming IS and Community Partnership Seminar on Study Design! This hybrid seminar will be held on February 22, from 5:30-7PM EST. We will be hearing from Subject Matter Expert, Laura Beres, PhD, MPH, Assistant Research Professor at Johns Hopkins University. We will also be hearing from Nina Yamanis, PhD, MPH, Associate Professor at American University, and DC CFAR SBS Core Co-Director. Please RSVP at the link below. Snacks and refreshments will be provided.
Register here
| | |
Howard University Investigators, Drs. Nekhai, Haddad, and Burke, receive Research Centers in Minority Institutions (RCMI)-CFAR Supplemental Grants |  | |
Howard University faculty Dr. Sergai Nekhai, DC CFAR Basic Sciences Core Director, Dr. Georges Haddad, Director of the Investigator Development Program for the Howard University RCMI program, and Dr. Mark Burke, DC CFAR Developmental Core Co-Director have been awarded Research Center in Minority Institutions (RCMI)-CFAR supplemental awards to support HIV/AIDS research.
Dr. Nekhai's project is entitled “Increased risk of HIV-1 infection among African Americans with Ferroportin Q248H mutation.” Dr. Seble Kassaye (GU) is a co-Investigator in this project and she will facilitate access and screening of MACS cohort participants. Drs. Haddad and Burke's project is entitled “The cardiovascular effects of gestational and perinatal combined antiretroviral therapy (cART),” and this project builds upon Dr. Haddad's DC CFAR 2022 Pilot Award, "Effects of cART on the Heart."
| |
Dr. Manya Magnus, DC CFAR Co-Director, named Chair of Department of Epidemiology at GW Milken Institute School of Public Health | |
On January 2nd, The Milken Institute School of Public Health at the George Washington University (GW) announced that Manya Magnus, PhD, MPH, had been named Chair of the Department of Epidemiology.
Dr. Magnus serves as Co-Director of the DC CFAR, Clinical Trials Unit (CTU) Leader and contact MPI for the DC CTU and the Evaluation Lead for the CFAR Diversity, Equity and Inclusion Pathway Initiative (CDEIPI) Program. Previously Dr. Magnus served as the Co-Director of the DC CFAR Clinical and Population Sciences Core.
Dr. Magnus's expertise includes clinical trials research, biomedical and structural interventions to prevent HIV transmission, advanced epidemiologic methods and analysis, research design, implementation, and regulatory coordination, program evaluation, and community engagement in HIV research.
Please read the full story here. Congratulations to Dr. Magnus!
| | |
Do you have an event you would like to see included in the next edition of the Community Spotlight? We invite any news or updates from the DC CFAR community and encourage you to send information that may be of interest to CFARinDC@gmail.com. | |
|
CROI: Conference on Retroviruses and Opportunistic Infections 2024 (Abstract Submission here)
March 3-6, 2024
Denver, CO
Inter-CFAR Substance Use Research Community (I-SURC) Networking Meeting (During CROI) - Are you attending CROI and interested networking with other substance use researchers? Register now!
March 3, 2024
Denver, CO
Save the Date – National 2024 Ryan White Conference on HIV & Treatment (AIDSWatch)
March 17-19, 2024
Washington, DC
Save the Date: MACC School of Nursing (SON) Conference
May 2-3, 2024
Baltimore, MD
NEW – ACTHIV 2024: Registration Open
May 2-4, 2024
Atlanta, GA | Online
SYNC 2024: Registration Now Open & Call for Abstracts
May 29-31, 2024
Washington, DC
IAS 2024
July 22-26
Munich, Germany
National LGBTQ+ Health Conference
August 15-17, 2024
Atlanta, GA
2024 National Ryan White Conference on HIV Care & Treatment
August 20-23, 2024
For more DC CFAR events please see the calendar here.
| |
FUNDING, TRAINING, & MENTORING OPPORTUNITIES & SEMINARS | |
|
JIAS Symposium: Advancing Use of Long-Acting HIV Treatment and Prevention Regimens, Friday, Feb 2, 2024, 10am EST
The symposium will highlight some key findings from the supplement published in July 2023 and will offer a comprehensive overview of the ongoing research on long-acting regimens. It will include community perspectives, explore future directions, and conclude with a panel discussion. Register here
Intersectionality Summer Intensive, Application due Feb 9, 2024
The Intersectionality Training Institute is accepting applications for the third cohort of its Intersectionality Summer Intensive. The Intersectionality Summer Intensive (ISI 2024) is a weeklong in-person training designed for researchers interested in learning how to apply intersectionality to their qualitative, quantitative, or mixed methods research projects. Lisa Bowleg, PhD, MA and Greta Bauer, PhD, MPH, leading experts of intersectionality, developed ISI ’24 to be a transformative, intellectually stimulating, and engaging environment where researchers and practitioners can meet, learn, and build community with other researchers, scholars, and practitioners who are passionate about applying intersectionality to health equity research, including HIV-related projects. ISI ’24 will be held in Philadelphia, PA from July 8 through July 12, 2024. We are thrilled to share that Dr. Patricia Homan will be our distinguished guest and facilitator. Dr. Homan, Associate Professor of Sociology and Associate Director of the Public Health Program at Florida State University, is in the vanguard of research and scholarship on structural intersectionality and health equity research. The deadline to apply is Friday, February 9th at 11:59 PM EST. Apply here or visit the ITI ’24 site at https://www.intersectionalitytraining.org/summer-intensive/. Have questions? Email the Intersectionality Training Institute at info@intersectionalitytraining.org.
Michigan Integrative Well-Being and Inequality (MIWI) Training Program, Application due Feb 15, 2024
Come train with us! The Michigan Integrative Well-Being and Inequality (MIWI) Training Program is accepting applications through 2/15/2024. We provide early career researchers (MD, PhD, ScD, DrPH, EdD, etc.) applied training on innovative methods for understanding the links between mental and physical health, with a focus on how these links relate to minority health and health disparities. We provide mentorship from senior experts, and the opportunity to learn with like-minded, creative peers. Learn more and apply here.
Applications for the Latino Scholars for HIV/AIDS Research Education (SHARE) 2024 Summer Program, Apply Now
The Latino SHARE program is an innovative 10-week summer mentored internship and learning experience for eligible undergraduate students from Hispanic/Latino communities. Based in Washington, DC at the George Washington University, the goal of this program is to support Hispanic/Latino undergraduates interested in pursuing further studies and careers in HIV/AIDS and substance abuse related research. The application deadline is February 16, 2024, at 11:59 PM EST. Learn more about the SHARE program and how to apply at latinoshare.gwu.edu
NEW – Workshop for Early Career Investigators in HIV, April 24, 2024, 11AM–4PM ET
The National Institutes of Health (NIH) Office of AIDS Research (OAR), along with the NIH institutes, centers, and offices (ICOs) with HIV research programs invite you to attend the Workshop for Early Career Investigators in HIV on Wednesday, April 24, 2024. OAR looks forward to building on the enthusiasm and feedback from the first two early career investigator (ECI) workshops in 2022 and 2023. OAR’s goal is to continue to provide knowledge, resources, and mentoring to the next generation of HIV investigators. Register here.
| |
NIH FUNDING OPPORTUNITIES
| |
|
HIV Cure-Related Research in Diverse Populations
Funding Opportunity Number: NOT-AI-23-046
Posting Date: June 23, 2023
Opening Date: September 07, 2023
Close Date: May 08, 2026
HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed)
Funding Opportunity Number: PAR-23-225
Posting Date: June 27, 2023
Opening Date: August 07, 2023
Close Date: Various – See announcement
Addressing the Impact of Syndemics on the Health of People with HIV and Diseases and Conditions within the Missions of NIDDK and NHLBI (R01 Clinical Trial Optional)
Funding Opportunity Number: RFA-DK-25-001
Posting Date: November 30, 2023
Opening Date: February 20, 2024
Close Date: Various – See announcement
Engineering and Preclinical Development of Biological Products that Eliminate HIV-infected Cells (UG3/UH3 Clinical Trial Not Allowed)
Funding Opportunity Number: RFA-AI-23-060
Posting Date: October 25, 2023
Opening Date: February 13, 2024
Close Date: March 14, 2024
Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional)
Funding Opportunity Number: PAR-23-112
Posting Date: January 31, 2023
Opening Date: February 24, 2023
Close Date: Various – See announcement
Engaging Survivors of Sexual Violence and Trafficking in HIV and Substance Use Disorder Services (R34 Clinical Trial Optional)
Funding Opportunity Number: RFA-DA-25-018
Posting Date: August 21, 2023
Opening Date: July 5, 2024
Close Date: August 2024
Addressing HIV in Highest Risk Sexual and Gender Minorities (R01 Clinical Trial Optional)
Funding Opportunity Number: RFA-DA-25-001
Posting Date: July 31, 2023
Opening Date: July 14, 2024
Close Date: August 14, 2024
Addressing HIV in highest risk sexual and gender minorities (R34 Clinical Trial Required)
Funding Opportunity Number: RFA-OD-23-018
Posting Date: July 31, 2023
Opening Date: July 14, 2024
Close Date: August 14, 2024
| |
|
Opportunities for HIV Cure Strategies at the Time of ART Initiation (R01 Clinical Trial Not Allowed)
Funding Opportunity Number: PAR-23-297
Posting Date: September 19, 2023
Opening Date: December 07, 2023
Close Date: Various – See announcement
Resources Access for Preclinical Integrated Drug Development (RAPIDD) Program (X01 Clinical Trial Not Allowed)
Funding Opportunity Number: PAR-22-185
Posting Date: May 27, 2022
Opening Date: December 07, 2023
Close Date: Various – See announcement
NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed)
Funding Opportunity Number: PAR-23-198
Posting Date: June 02, 2023
Opening Date: September 13, 2023
Close Date: Various – See announcement
Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R01 Clinical Trial Optional)
Funding Opportunity Number: PAR-23-061
Posting Date: January 11, 2023
Opening Date: April 09, 2023
Close Date: January 10, 2026
Formative and Pilot Intervention Research to Optimize HIV Prevention and Care Continuum Outcomes (R34 Clinical Trial Optional)
Funding Opportunity Number: PAR-23-060
Posting Date: January 11, 2023
Opening Date: April 09, 2023
Close Date: January 10, 2026
Notice of Special Interest (NOSI): Implementation Science to Advance the United States HIV Prevention and Treatment Goals and the Global HIV Prevention and Treatment Targets
Funding Opportunity Number: NOT-MH-23-275
Posting Date: June 5, 2023
Opening Date: September 07, 2023
Close Date: September 08, 2026
Notice of Special Interest (NOSI): Research on HIV-associated Malignancies
Funding Opportunity Number: NOT-CA-23-070
Posting Date: June 5, 2023
Opening Date: September 07, 2023
Close Date: September 08, 2026
| |
Click here for additional funding opportunities available from the National Institutes of Health. | |
The DC CFAR is an NIH funded program (P30AI117970), which is supported by the following NIH Co-Funding and Participating Institutes and Centers: NIAID, NCI, NICHD, NIDCR, NHLBI, NIDA, NIMH, NIA, NIDDK, NINR, NIMHD, FIC, and OAR. The content isthe responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. | | |
| | | |
